NCT06907628View on ClinicalTrials.gov

A Trial of SHR-3792 Injection in Patients With Advanced Solid Tumors

PHASE1RecruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

April 2, 2025

Primary Completion Date

February 28, 2027

Study Completion Date

February 28, 2027

Conditions
Advanced Solid Tumors
Interventions
DRUG

SHR-3792 Injection

SHR-3792 injection.

Trial Locations (1)

250117

RECRUITING

Shandong First Medical University Affiliated Cancer Hospital, Jinan

All Listed Sponsors
lead

Suzhou Suncadia Biopharmaceuticals Co., Ltd.

INDUSTRY